Your browser doesn't support javascript.
loading
Detection of cutaneous prion protein deposits could help diagnose GPI-anchorless prion disease with neuropathy.
Honda, Hiroyuki; Matsuzono, Kosuke; Satoh, Kota; Fujisawa, Masayoshi; Suzuki, Satoshi O; Furuyama, Chiaki; Kitamoto, Tetsuyuki; Fujimoto, Shigeru; Abe, Koji; Iwaki, Toru.
Afiliação
  • Honda H; Department of Neuropathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Matsuzono K; Division of Neurology, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan.
  • Satoh K; Department of Neurology, Okayama University Graduate School of Medicine, Okayama, Japan.
  • Fujisawa M; Department of Pathology and Experimental Medicine, Graduate School for Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
  • Suzuki SO; Department of Neuropathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Furuyama C; Division of Dermatology, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan.
  • Kitamoto T; Division of CJD Science and Technology, Department of Neurological Science, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Fujimoto S; Division of Neurology, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan.
  • Abe K; Department of Neurology, Okayama University Graduate School of Medicine, Okayama, Japan.
  • Iwaki T; Department of Neuropathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Eur J Neurol ; 28(6): 2133-2137, 2021 06.
Article em En | MEDLINE | ID: mdl-33420752
ABSTRACT
BACKGROUND AND

PURPOSE:

To investigate prion protein (PrP) deposits in cutaneous tissues of patients of glycosylphosphatidylinositol (GPI)-anchorless prion diseases with neuropathy.

METHODS:

Cutaneous tissue samples from three patients with GPI-anchorless prion diseases were obtained, two cutaneous biopsy samples from the lower leg of Case 1 (Y162X) and Case 3 (D178fs25), and a cutaneous sample taken from the abdomen during an autopsy of Case 2 (D178fs25). We performed immunohistochemistry for PrP to look for abnormal PrP deposits.

RESULTS:

PrP deposits were observed in the dermal papilla, the sweat glands, the hair follicles, the arrector pili muscles, and peripheral nerves of all examined cases of GPI-anchorless prion disease with neuropathy. The abnormal PrP accumulation was frequently localized at the basement membrane, and colocalized with laminin.

CONCLUSION:

Immunohistochemical detection of PrP in cutaneous samples could be used to definitively diagnose GPI-anchorless PrP disease with neuropathy.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Priônicas / Proteínas Priônicas Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Priônicas / Proteínas Priônicas Idioma: En Ano de publicação: 2021 Tipo de documento: Article